Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality

To assess the prevalence of disease- and therapy-related complications and of the organ damage after a follow-up of 15 years or more in patients with primary antiphospholipid syndrome (PAPS).